<p class="doc-ti" id="d1e39-22-1" style="font-weight: 600; font-style: italic; text-align: center;">COMMISSION IMPLEMENTING DECISION (EU) 2016/375</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">of 11 March 2016</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">authorising the placing on the market of lacto-<span class="italic">N</span>-neotetraose as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council</p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;"> <span class="sp-normal"> <span class="italic">(notified under document C(2016) 1419)</span> </span> </p><p class="doc-ti" style="font-weight: 600; font-style: italic; text-align: center;">(Only the Danish text is authentic)</p><section><p class="normal">THE EUROPEAN COMMISSION,</p><p class="normal">Having regard to the Treaty on the Functioning of the European Union,</p><p class="normal">Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, and in particular Article 7 thereof,</p><p class="normal">Whereas:</p><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(1)</p> </td> <td valign="top"> <p class="normal">On 15 January 2014, the company Glycom A/S made a request to the competent authorities of Ireland to place lacto-<span class="italic">N</span>-neotetraose on the market as a novel food ingredient.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(2)</p> </td> <td valign="top"> <p class="normal">On 10 June 2014, the competent food assessment body of Ireland issued its initial assessment report. In that report, it came to the conclusion that lacto-<span class="italic">N</span>-neotetraose meets the criteria for novel food set out in Article 3(1) of Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(3)</p> </td> <td valign="top"> <p class="normal">On 7 July 2014, the Commission forwarded the initial assessment report to the other Member States.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(4)</p> </td> <td valign="top"> <p class="normal">Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(5)</p> </td> <td valign="top"> <p class="normal">On 13 October 2014, the Commission consulted the European Food Safety Authority (EFSA), asking it to carry out an assessment for lacto-<span class="italic">N</span>-neotetraose as a novel food ingredient in accordance with Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(6)</p> </td> <td valign="top"> <p class="normal">On 29 June 2015, EFSA in its ‘Scientific Opinion on the safety of lacto-<span class="italic">N</span>-neotetraose as a novel food ingredient pursuant to Regulation (EC) No 258/97’, concluded that lacto-<span class="italic">N</span>-neotetraose is safe for the proposed uses and use levels.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(7)</p> </td> <td valign="top"> <p class="normal">On 5 October 2015, the applicant sent a letter to the Commission and provided additional information to support the use and approval of 2′-<span class="italic">O</span>-fucosyllactose and lacto-<span class="italic">N</span>-neotetraose in food supplements for general population (excluding infants) under Regulation (EC) No 258/97.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(8)</p> </td> <td valign="top"> <p class="normal">On 14 October 2015, the Commission consulted EFSA asking it to carry out an assessment of the safety of these novel foods in food supplements also for children (excluding infants).</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(9)</p> </td> <td valign="top"> <p class="normal">On 28 October 2015, EFSA in its ‘Statement on the safety of lacto-<span class="italic">N</span>-neotetraose and 2′-<span class="italic">O</span>-fucosyllactose as novel food ingredients in food supplements for children’, concluded that lacto-<span class="italic">N</span>-neotetraose is safe for the proposed uses and use levels.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(10)</p> </td> <td valign="top"> <p class="normal">Commission Directive 96/8/EC lays down requirements on foods intended for use in energy-restricted diets for weight reduction. Commission Directive 1999/21/EC lays down requirements for dietary foods for special medical purposes. Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements. Commission Directive 2006/125/EC lays down requirements for processed cereal-based foods and baby foods for infants and young children. Commission Directive 2006/141/EC lays down requirements for infant formulae and follow-on formulae. Regulation (EC) No 1925/2006 of the European Parliament and of the Council lays down requirements on the addition of vitamins and minerals and of certain other substances to foods. Commission Regulation (EC) No 41/2009 lays down requirements for the composition and labelling of foodstuffs suitable for people intolerant to gluten. Commission Implementing Regulation (EU) No 828/2014 lays down the requirements for the provision of information to consumers on the absence or reduced presence of gluten in food. The use of lacto-<span class="italic">N</span>-neotetraose should be authorised without prejudice to the requirements of those legislations.</p> </td> </tr> </tbody> </table><table border="0" cellpadding="0" cellspacing="0" width="100%"> <col width="4%"/> <col width="96%"/> <tbody> <tr> <td valign="top"> <p class="normal">(11)</p> </td> <td valign="top"> <p class="normal">The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,</p> </td> </tr> </tbody> </table><p class="normal">HAS ADOPTED THIS DECISION:</p></section> <section><p class="ti-art" id="d1e303-22-1" style="font-style: italic; text-align: center;">Article 1</p><p class="normal">Lacto-<span class="italic">N</span>-neotetraose as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to the specific provisions of Directives 96/8/EC, 1999/21/EC, 2002/46/EC, 2006/125/EC, 2006/141/EC and Regulations (EC) No 1925/2006, (EC) No 41/2009 and Implementing Regulation (EU) No 828/2014.</p></section> <section><p class="ti-art" id="d1e311-22-1" style="font-style: italic; text-align: center;">Article 2</p><p class="normal">1. The designation of lacto-<span class="italic">N</span>-neotetraose authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘lacto-<span class="italic">N</span>-neotetraose’.</p><p class="normal">2. Information shall be given to the consumer that food supplements containing lacto-<span class="italic">N</span>-neotetraose should not be used if other foods with added lacto-<span class="italic">N</span>-neotetraose are consumed the same day.</p><p class="normal">3. Information shall be given to the consumer that food supplements containing lacto-<span class="italic">N</span>-neotetraose intended for young children should not be used if breast milk or other foods with added lacto-<span class="italic">N</span>-neotetraose are consumed the same day.</p></section> <section><p class="ti-art" id="d1e351-22-1" style="font-style: italic; text-align: center;">Article 3</p><p class="normal">This Decision is addressed to Glycom A/S, Diplomvej 373, 2800 Kgs. Lyngby, Denmark.</p></section>